Skip to main content

Racial Disparity Seen in Naloxone Administration

Medically reviewed by Carmen Pope, BPharm. Last updated on June 3, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, May 31, 2024 -- In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic people, according to a study published online May 29 in Addiction.

Erin Takemoto, Ph.D., M.P.H., from the Pennsylvania Department of Health in Harrisburg, and colleagues characterized the circumstances of drug overdose deaths to determine whether naloxone administration differed by overdose decedent race and ethnicity. The analysis included data on unintentional and undetermined-intent drug overdose deaths in Pennsylvania (2019 to 2021) as identified from death certificates and the State Unintentional Drug Overdose Reporting System.

The researchers found that overdose death rates were the highest among Black people and increased over time (4.3, 6.1, and 6.5 per 10,000 population for 2019, 2020, and 2021, respectively), while rates were lowest among White people and remained constant over time (2.6, 2.7, and 2.6 per 10,000 population for 2019, 2020, and 2021, respectively). Across the study period, Black decedents had approximately 40 to 50 percent lower odds of receiving naloxone versus White decedents (odds ratios, 0.7, 0.5, and 0.6 for 2019, 2020, and 2021, respectively). Hispanic decedents had similar odds of naloxone administration as White decedents.

"Naloxone distribution strategies should be thoughtfully and purposefully implemented to guarantee its availability, such that anyone who suffers an overdose has an equal chance of survival, irrespective of their racial or ethnic background," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Considerable Gaps Seen in Provision of Effective Treatment for Opioid Addiction

TUESDAY, July 16, 2024 -- There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment...

12.7 Percent of Adults Using Fentanyl or Heroin Report Ever Using Xylazine

MONDAY, July 8, 2024 -- A considerable proportion of adults reporting illegally manufactured fentanyl (IMF) or heroin use also use xylazine, according to research published in the...

Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them

THURSDAY, June 27, 2024 -- Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.